← All organizations

Spero Therapeutics

For profitWebsite ↗

Also known as: Spero Therapeutics | Spero Therapeutics Inc | Spero Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 20, 2024

Timeline

2010s

Jun 1, 2013
Spero Therapeutics— Founded

Drugs by trial phase (23 distinct, 23 trials)

Phase 3 (4 own, 0 via acquisition)

Phase 2 (6 own, 0 via acquisition)

Phase 1 (13 own, 0 via acquisition)

Indications

Studied for

Recent trials (32)

NCT06727136Lead sponsorPhase 1Nov 20, 2024
NCT06059846Study directorPhase 3Nov 30, 2023
NCT06059846Lead sponsorPhase 3Nov 30, 2023
NCT05966688Lead sponsorPhase 1Aug 4, 2023
NCT05955586Lead sponsorPhase 1Aug 1, 2023
NCT05856747Lead sponsorPhase 1May 4, 2023
NCT05496374Lead sponsorPhase 2Dec 31, 2022
NCT05496374Study directorPhase 2Dec 31, 2022
NCT04919954CollaboratorPhase 1Aug 31, 2021
NCT04865393Study directorPhase 1Jun 8, 2021
NCT04865393Lead sponsorPhase 1Jun 8, 2021
NCT04868292Study directorPhase 1Jun 3, 2021
NCT04868292Lead sponsorPhase 1Jun 3, 2021
NCT04710407Lead sponsorPhase 1Dec 7, 2020
NCT04553406Lead sponsorPhase 1/Phase 2Nov 10, 2020

Details

Founded: Cambridge, MA, US Jun 1, 2013
Last known activity: Nov 20, 2024